By Josh White
Date: Tuesday 12 Aug 2025
(Sharecast News) - PureTech Health announced the launch of Celea Therapeutics on Tuesday, a new company focused on developing treatments for serious respiratory diseases, led by former Teva North America chief executive Sven Dethlefs.
By Michele Maatouk
Date: Wednesday 16 Jul 2025
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health said on Wednesday that chief executive officer Bharatt Chowrira has stepped down with immediate effect.
By Benjamin Chiou
Date: Wednesday 30 Apr 2025
(Sharecast News) - PureTech Health impressed the market with its annual results for 2024, as the company maintained a strong cash position while hitting a number of key clinical and regulatory milestones during the year.
Currency | UK Pounds |
Share Price | 134.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 173.60 |
52 Week Low | 103.00 |
Volume | 487,131 |
Shares Issued | 241.32m |
Market Cap | £323.36m |
Beta | 0.03 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
17:07 | 5,000 @ 134.00p |
16:35 | 30,000 @ 134.00p |
16:35 | 105,496 @ 134.00p |
16:35 | 2,989 @ 134.00p |
16:35 | 641 @ 134.00p |
You are here: research